Agios Pharmaceuticals, Inc. (AGIO) vs Immunome, Inc. (IMNM)
- Agios Pharmaceuticals, Inc. AGIO 31.32 −3.09%
- Immunome, Inc. IMNM 16.47 −5.34%
Agios Pharmaceuticals, Inc. and Immunome, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Immunome, Inc. are of similar size ($2.1B and $1.9B). Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 140.6% against 16.7%. Immunome, Inc. has the higher net margin (0.00% vs −418.2%) and the lower return on invested capital (−3,323.0% vs −70.2%). Across the 16 metrics below, Agios Pharmaceuticals, Inc. leads on 8 and Immunome, Inc. on 8.
Valuation
Profitability
| Metric | AGIO | IMNM | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.99% | 100.00% | 65.16% |
| Operating margin | (466.78%) | 0.00% | 0.00% |
| Net margin | (418.24%) | 0.00% | 0.00% |
| Free cash flow margin | (371.43%) | 0.00% | 0.00% |
| Return on equity | (34.34%) | (64.03%) | (56.36%) |
| Return on assets | (31.89%) | (59.03%) | (48.04%) |
| Return on invested capital | (70.24%) | (3,322.99%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack